Leveraging US FDA & CE Marks for AI Medical Devices in Singapore: An ASEAN Market Guide by Pure Global
MP3•Episode home
Manage episode 507049858 series 3684626
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
This episode of ASEAN MedTech Insights dives into a crucial question for global MedTech companies: Does Singapore's Health Sciences Authority (HSA) recognize foreign approvals for AI-powered medical devices? We explore how securing clearance from major bodies like the US FDA or receiving a CE Mark in Europe can be a powerful asset, but not an automatic ticket, for market entry into Singapore. We break down the HSA's reference agency framework and explain the different evaluation pathways available to foreign manufacturers. Discover the specific requirements for Software as a Medical Device (SaMD), the critical role of a local Singapore Registrant, and why your existing technical documentation needs careful adaptation for a successful submission. This is your essential guide to leveraging your global wins for local success in the ASEAN region. Consider a startup with a groundbreaking AI diagnostic tool that just earned its CE Mark. They're eyeing the dynamic Singapore market, but the thought of a new, full-scale regulatory battle is daunting. Is their hard-won European approval and clinical data useful? This episode reveals how they can turn that existing approval into their most powerful asset for an accelerated and streamlined market entry. Key questions answered in this episode: 1. What are Singapore's "reference agencies" and why are they critical for your market entry strategy? 2. Does having FDA approval mean you can automatically sell your AI device in Singapore? 3. How does the HSA classify and regulate AI-powered medical software (SaMD)? 4. What are the different evaluation pathways and how do you qualify for the fastest one? 5. Why is a local Singapore Registrant non-negotiable for foreign manufacturers? 6. What specific documentation is required even for an abridged review process? 7. How does the international IMDRF framework influence Singapore's SaMD regulations? At Pure Global, we specialize in transforming these complex regulatory landscapes into clear, actionable strategies. Our team offers end-to-end solutions, from acting as your local Singapore Registrant to compiling your technical dossier using advanced AI tools. We turn regulatory hurdles into pathways for growth. Ready to accelerate your entry into the ASEAN market? Contact us at [email protected] or visit https://pureglobal.com/ to learn more.
…
continue reading
30 episodes